But a few months later the momentum ground to a halt when FDA reviewers raised questions about the ATLAS trial.

FORBES: FDA Again Rejects ACS Indication for Rivaroxaban (Xarelto)

Woods later said he purposed dropped it a few yards back to avoid hitting the pin, and more questions were brought to Ridley's attention later that night.

NPR: Former Official TV Viewer On Tiger Drop